Our mission to repair the damage caused by neurological diseases covers both the central and peripheral nervous system diseases. Neuropathy will damage the neurons of over 25% of Americans, and results in damaged nerves, pain, decreased functional mobility and increased mortality. Neuropathy is a significant driver of the opioid crisis and is a sequalae of the rampant diabetes epidemic impacting 70 million patients.
There are currently no approved products that inhibit, delay, or reverse nerve damage – the underlying cause of the symptoms associated with neuropathy. Currently available treatments have significant side effects while leaving a majority of patients with unresolved pain. We are developing novel treatments that impact disease progression through nerve regeneration, and manage the painful symptoms of neuropathy.